Fundraising Fox
Humboldt
Venture capitalNew York · Pre-Seed–Series A · 4 people tracked
Also known as HUMBOLDT CAPITAL, LLC
Find your way into Humboldt
Each arrow is one introduction. Sign up to fill in the first one.
Ask Matthias Van Woensel to introduce you to Sebastian Bernales
You →Matthias · together at Alesta →Sebastian
Ask Jamie Chen to introduce you to Francisco Dopazo
You →Jamie · together at Humboldt →Francisco
Ask Sam Okafor to introduce you to Benjamin Quiroga
You →Sam · together at Humboldt →Benjamin
- Michelle Nacouzi56 people can intro you
Sign up to find every way you can get introduced to Humboldt
- Your email: who you already know at Humboldt, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Humboldt team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Exclusive synthetic biology investor focused on companies replacing industrial inputs with biology-based alternatives, led by a UCSF-trained PhD cell biologist offering deep research expertise and global Latin America–Europe reach.
Source: firm website, verified Sep 29, 2026.
Team · 4 people
from curated & public directoriesWhat they invest in
from 25 of 28 portfolio companiesBiotech ×18Healthtech ×10AI & Machine Learning ×7Deep Tech ×5Medical Devices ×5Digital Health ×3FoodTech ×3Climate Tech ×2
HQs:United States×15Chile×3Argentina×1
Investments · 28 tracked
founders shown can be your intro pathBy year:2023 · 12022 · 22021 · 12020 · 12018 · 27 dated
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical DevicesBerkeley, US
Brian Thomas(Executive Officer, Director, Promoter)in
BoardAndrew Farquharson(Director)inJak Knowles(Director)
Board seatSebastian Bernales· per SEC Form D
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesInCube Ventures+5 more
Revr (SynVitro Bio) designs functional proteins by combining AI models with large-scale biophysical data generated from an automated wet lab platform, using a closed-loop process to speed up protein refinement.
AI & Machine LearningBiotechDeep TechHealthtechSan Leandro, US
Zachary Sun(Executive Officer, Director)Michael Nemzek(Executive Officer, Director)Corinna Chen(CEO)
Board seatFrancisco Dopazo· per SEC Form D · $17.6M raise · filed Sep 2023
Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities.
BiotechHealthtechLongevity
Co-investorsAgent CapitalOlive Tree CapitalService Provider CapitalFred Hutchinson Cancer Research CenterLeaps by BayerVida Ventures
Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods.
BiotechDeep TechHealthtechEmeryville, US
Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inDaniel Lin-Arlow(Executive Officer, Director)inDaniel Hillel Lin-Arlow(Executive Officer, Director)Jason T. Gammack(Executive Officer, Director)in
BoardYanniv Dorone(Director)
Co-investorsCarbon SiliconCerberus VenturesDauntless VenturesFifty YearsJude GomilaMetaplanet+12 more
Blueberry Pediatrics provides 24/7 telemedicine consultations with board-certified pediatricians for families, supplemented by an at-home diagnostic kit to expand diagnosis capabilities and reduce urgent care visits.
Digital HealthHealthtechSan Francisco, US
Harrison Gordon(Founder/CEO)in
Co-investorsColle Capital PartnersMS&AD VenturesSGH CapitalStreamlined VenturesVentureSouqVibe Capital+12 more
Cellineobio develops cell engineering and bioprocess technology platforms.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
Nabiha Saklayen, PhD(Co-Founder & CEO)inMarinna Madrid, PhD(Co-Founder & Chief Product Officer)inNabiha Saklayen(Executive Officer, Director)inMatthias Wagner(Executive Officer, Director)in
Co-investors8VCCota CapitalFelicis VenturesHAWKTAILKhosla VenturesThe Engine Ventures+1 more
Debut applies AI and biotechnology to discover and formulate cosmetic ingredients and beauty products, decoding skin and hair at the genomic level to create novel actives.
Advanced ManufacturingAI & Machine LearningBiotechConsumerSan Diego, US
Joshua Britton(Founder)in
BoardCain A. McClary(Director)in
Co-investorsGS FuturesMaterial ImpactBreakout VenturesKdT VenturesSandbox IndustriesACVC Partners+11 more
Endpoint Health develops precision medicine tools and targeted therapies for patients with critical illnesses like sepsis and ARDS, leveraging big data and AI to personalize treatment.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Jose, US
Jason Springs(Co-Founder, CEO)Diego Rey(Co-Founder, CSO)Leonardo Teixeira(Co-Founder, COO)Jeff Osborn(Co-Founder, CTO)
Co-investorsWireframe Ventures
Endpoint Health develops immunology-focused therapeutics paired with diagnostic tests designed to match individual patients with treatments suited to their biology for critical and chronic illnesses.
BiotechHealthtechSan Francisco, US
Diego Rey(Founder/CSO)inJeff Osborn(Founder)inJason Springs(Founder)inLeonardo Teixeira(Founder)in
Co-investorsAlix VenturesGlobal Health Investment CorporationKnockout CapitalY CombinatorAME Cloud VenturesBoom Capital Ventures+5 more
Examedi provides at-home blood tests and telemedicine consultations available 24/7 in Chile.
Digital HealthHealthtechMarketplacesSantiago, CL
Andres Kemeny(Founder)inJuan Pablo Zepeda(Founder)inEun Bin Lee(Director)
Co-investorsGeneral CatalystY CombinatorFJ LabsNexus Venture PartnersPlatanus Ventures
.png)
Filadd offers online test-preparation courses for college entrance exams in Chile, Brazil, Argentina, and Colombia, featuring video lessons, live tutoring, and AI-generated study plans tailored to individual students.
EdTechCórdoba, AR
Joaquin olmedo(Founder)inGuillermo Bruchmann Tanodi(Founder)inNicolás Ferrer(Founder)inAgustin Trombotto(Founder)in
Co-investorsY CombinatorAlaya CapitalIncutex
Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.
BiotechHealthtechMedical DevicesSomerville, US
Mark Smith(Executive Officer, Director)inMatt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)
Co-investorsAvenir Growth CapitalB3 HoldingKleinmuntz AssociatesOctave Ventures LlcOCV PartnersOMX Ventures+2 more
Finless Foods develops cell-cultivated seafood alternatives, starting with Pacific bluefin tuna, aimed at consumers seeking sustainable options that reduce pressure on wild fish stocks.
BiotechClimate TechFoodTech
Brandon Chen(Co-Founder & CEO)inBrian Wyrwas(Co-Founder & CSO)inMichael Selden(Co-Founder & Advisor)in
Co-investorsAt One VenturesAurum Venture PartnersBabel VenturesBlue Horizon CorporationBlue Revolution Investments G.P.Draper Associates+10 more
Fintoc provides an API for businesses to automate payment identification, reconciliation, and transfers in Mexico, enabling large-scale collection and disbursement of SPEI transfers.
Developer ToolsFintechSaaSSantiago, CL
Cristóbal Griffero(Founder)inLukas Zorich(Founder)in
Co-investorsBrighter CapitalMONASHEESPlatanus VenturesPropel Venture PartnersSoma CapitalY Combinator+5 more
GCTx develops an induced pluripotent stem cell (iPSC) programming platform called TFome™ that uses synthetic biology, gene editing, and machine learning to improve cell therapy development and scaling.
AI & Machine LearningBiotechMedical DevicesCambridge, US
George Church(Co-Founder & Scientific Advisor)Parastoo Khoshakhlagh(Chief Executive Officer & Co-Founder)inAlex Ng(Chief Innovation Officer & Co-Founder)in
Co-investorsAlumni VenturesAndreessen HorowitzGlobal BrainMedical Excellence Capital
Geltor uses a proprietary biodesign and precision fermentation platform to create and commercially produce novel protein ingredients, including collagens, for beauty and personal care formulators.
BiotechFoodTechNew MaterialsWellness & Fitness
Alexander Lorestani(Founder)inNick Ouzounov(Co-founder)in
Co-investorsAgronomicsAlwyn CapitalArgonautic VenturesBaruch Future VenturesBlue Horizon CorporationBoxGroup+17 more
HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.
AI & Machine LearningBiotechDeep TechHealthtech
Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)inDaniel Blessing(Chief Scientific Officer (CSO) & Co-founder)inRichard Law(Chief Business Officer (CBO))inEric Adam(Chief Operating Officer (COO))inJordan Shin(Chief Medical Officer (CMO))inJérôme Andries(Chief Financial Officer (CFO))in
Co-investorsBroadview VenturesSofinnova PartnersApollo Health Ventures+ND Capital4see Ventures
Houm is a proptech platform that helps property owners list and rent residential properties in Latin America.
MarketplacesPropTechSantiago, CL
Benjamín Labra(Founder)inNicolas Knockaert(Founder)inBenjamin Ignacio Labra Zelaya(Executive Officer, Director)Benjamin Labra(Founder)in
BoardJorge Benitez(Director)Jonathan Lewy(Director)
Co-investorsCapria VenturesCathexis VenturesCM VenturesEmles Venture PartnersFoundersX VenturesMagma Partners+23 more
Meadow provides software for cannabis dispensaries, offering inventory management, compliance automation, and reporting tools.
Enterprise SoftwareRetail TechSaaSSan Francisco, US
David Hua(Founder/CEO)inRick Harrison(Founder/CTO)inScott A Garman(Founder)inHarrison Lee(Founder/Designer, Developer)in
Co-investorsPioneerSoma CapitalY CombinatorAlleyCorpArcadian CapitalBBQ Capital+15 more
Dutch cultivated meat company that grew pork from pluripotent stem cells; wound down operations in December 2025.
Co-investorsBackedHAWKTAILAgronomicsBlueYard CapitalFuture Positive CapitalInvest-NL+1 more
Automates complex biological protocols in a compact cartridge-based system for genomic sequencing
BiotechSan Francisco, US
Ferran Galindo(Director)inFoteini Christodoulou(Director)
BoardAlejandro Tocigl(Executive Officer, Director)in
Co-investors0BSCota CapitalID345Kayyak VenturesNazcaSun Mountain Capital+1 more
Mission Barns produces cultivated meat products, primarily pork-based items like meatballs, bacon, and sausages, combining lab-grown pork fat with plant protein for consumers seeking sustainable alternatives to conventional meat.
Climate TechFoodTechBerkeley, US
Ilan Eitan Fischer(Executive Officer, Director)
BoardDavid Bowman(Director)
Co-investorsAir Street CapitalBabel VenturesBetter Ventures Central LlcBloom8Blue Ledge CapitalJoyance Partners+7 more
.png)
MycoWorks produces Reishi, a premium biomaterial made from Fine Mycelium, used as a sustainable leather alternative in furniture, design, and automotive products.
BiotechCircular EconomyNew MaterialsEmeryville, US
Philip Ross(Director)inMichael Lindheim(Executive Officer)Matthew Scullin(Executive Officer, Director)in
BoardKiersten Stead(Director)inThomas Grotkjaer(Director)
Co-investorsATEL VenturesDCVC (Data Collective)Hemisphere Ventures LLCValor Equity PartnersWireframe Ventures8VC+7 more
Phage Lab develops solutions to address bacterial outbreaks using a One Health approach, bringing together around 100 scientists and professionals from multiple disciplines in animal health and microbiology.
AgTechAI & Machine LearningBiotech
Pablo Cifuentes Palma(Founder)inHans Pieringer(Founder)in
Co-investorsCollaborative FundInvexor Venture PartnersNazcaThe Yield Lab LatamKaszek Ventures
Chilean food technology company that uses machine learning to reformulate animal-based foods such as mayonnaise, milk and burgers from plants.
Karim Pichara(Founder)in
Co-investorsGeneral CatalystMAYA Capital VenturesSustainable Food VenturesThe CraftoryBezos ExpeditionsCleveland Avenue+3 more
Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.
Biotech
Co-investorsBeresford VenturesCreative VenturesFifty YearsFREEFLOWMaterial ImpactIn-Q-Tel+2 more
Z Biotic develops genetically engineered probiotics designed to improve daily health and wellbeing.
BiotechConsumerHealthtechWellness & FitnessSan Francisco, US
Stephen Lamb(Founder)inZack Abbott(CEO)
Co-investorsAble PartnersBabel VenturesChampion Hill VenturesFJ LabsFundamental VenturesGoat Rodeo Capital+18 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Brightseed, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesMeatable · eu-startups.com · Dec 22, 2025
Geltor · geltor.com · Oct 13, 2025
Ansa Biotechnologies · finsmes.com · Oct 2, 2025
Frequently asked questions
- How many investments has Humboldt made?
- Humboldt has 28 tracked investments.
- What stage does Humboldt invest at?
- Humboldt invests at the Pre-Seed, Seed, Series A stages.
- What is Humboldt's typical check size?
- Humboldt typically writes checks of $100K – $5M.
- What sectors does Humboldt focus on?
- Humboldt focuses on AgTech, AI & Machine Learning, Biotech, FoodTech, Hardware, Healthtech, New Materials.
- Where is Humboldt located?
- Humboldt is headquartered in New York, US.
- Does Humboldt lead rounds?
- Humboldt typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamVentures #7 w/ Francisco Dopazo - General Partner @ Humboldt Fund | BIOS
BIOS · Francisco Dopazo
Co-investors · 5
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.
Apollo Health Ventures is a biotech-focused investor that combines traditional funding with venture building to back transformative healthcare and longevity companies in Europe and the US.
Broadview Ventures is an impact investor focused on accelerating the development of technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.
Causal is a financial planning and analysis platform that enables finance teams to move beyond traditional spreadsheet-based planning by integrating data from multiple sources and providing dynamic forecasting, budgeting, and scenario planning capabilities.
Tencent is a Chinese technology company operating consumer products such as Tencent Games and Weixin/WeChat, business services including Tencent Cloud, and technology research units like Tencent Media Lab and Ethereal Lab.
Firms observed investing alongside Humboldt, from public investor directories. Shared companies are the overlap with Humboldt's recorded portfolio.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
MPG Fund is an early-stage venture investor backing technology startups.
Unruly Capital is a venture capital firm investing in deep-tech and hard-science startups across biotech, health, manufacturing, energy, climate and related sectors, primarily in Europe and the United States.